Tackling Europe’s “Spice” Problem

Policy Brief February, 2015, No. 170

The increased prevalence of the drug “Spice” is a concern for European policymakers. The authors put forward the case that stronger EU cooperation on the issue, more funding for research and prevention, while shifting the burden of proof of legality to the manufacturers of such drugs, are all essential if Spice is to be tackled effectively.

Related Publications